$0.818700
-0.0095-1.15%
At Close: -
$0.833300
0.011.78%
After Hours: Jul 5, 6:01 PM EDT
15 minutes delayed
Karyopharm Therapeutics
KPTINASDAQ
Karyopharm Therapeutics (NASDAQ:KPTI) Stock, Earnings Estimates, EPS, And Revenue
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 31
EPS Estimate
$-0.310
Quarterly Revenue Estimate
$36.2M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$140.5M
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics | -$0.29 | -$0.31 | — | — | $37.58M | $36.18M | — | — | 07/31/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.30 | -$0.33 | -$0.32 | 3.03% | $38.70M | $34.47M | $33.13M | -3.90% | 05/08/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.43 | -$0.31 | -$0.36 | -16.13% | $33.58M | $35.40M | $33.75M | -4.67% | 02/29/2024 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.45 | -$0.28 | -$0.30 | -7.14% | $36.15M | $37.28M | $36.01M | -3.41% | 11/02/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.62 | -$0.34 | -$0.29 | 14.71% | $39.68M | $36.23M | $37.58M | 3.72% | 08/02/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.53 | -$0.37 | -$0.30 | 18.92% | $47.67M | $36.60M | $38.70M | 5.73% | 05/04/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | $0.46 | -$0.35 | -$0.43 | -22.86% | $126.27M | $35.12M | $33.58M | -4.38% | 02/15/2023 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.69 | -$0.57 | -$0.45 | 21.05% | $37.69M | $34.56M | $36.15M | 4.59% | 11/03/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.71 | -$0.63 | -$0.62 | 1.59% | $22.60M | $35.59M | $39.68M | 11.49% | 08/04/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.77 | -$0.63 | -$0.53 | 15.87% | $23.26M | $34.17M | $47.67M | 39.51% | 05/05/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.59 | -$0.49 | $0.46 | 193.88% | $35.10M | $50.49M | $126.27M | 150.09% | 02/08/2022 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.73 | -$0.67 | -$0.69 | -2.99% | $21.33M | $25.80M | $37.69M | 46.08% | 11/03/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.63 | -$0.74 | -$0.71 | 4.05% | $33.51M | $25.64M | $22.60M | -11.85% | 08/05/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.78 | -$0.71 | -$0.77 | -8.45% | $18.14M | $25.17M | $23.26M | -7.59% | 05/03/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.76 | -$0.59 | -$0.59 | 0.00% | $18.10M | $29.37M | $35.10M | 19.51% | 02/11/2021 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.67 | -$0.72 | -$0.73 | -1.39% | $13.15M | $21.45M | $21.33M | -0.55% | 11/02/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.71 | -$0.58 | -$0.63 | -8.62% | $9.49M | $27.42M | $33.51M | 22.22% | 08/04/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$1.09 | -$0.69 | -$0.78 | -13.04% | $155.00K | $21.28M | $18.14M | -14.77% | 05/05/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.96 | -$0.67 | -$0.76 | -13.43% | $206.00K | $16.34M | $18.10M | 10.75% | 02/13/2020 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.79 | -$0.84 | -$0.67 | 20.24% | $239.00K | $1.80M | $13.15M | — | 11/04/2019 | Get Alert |
| KPTI | Karyopharm Therapeutics | -$0.60 | -$0.98 | -$0.71 | 27.55% | $19.89M | $90.00K | $9.49M | 10447.78% | 08/06/2019 | Get Alert |
Karyopharm Therapeutics (KPTI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $-0.32 | $-0.33 | 3.03 % |
| Dec 2023 | 2024-02-29 | $-0.36 | $-0.31 | -16.1 % |
| Sep 2023 | 2023-11-02 | $-0.30 | $-0.28 | -7.14 % |
| Jun 2023 | 2023-08-02 | $-0.29 | $-0.34 | 14.7 % |
Karyopharm Therapeutics (KPTI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $33.13M | $34.47M | -3.90 % |
| Dec 2023 | 2024-02-29 | $33.75M | $35.40M | -4.67 % |
| Sep 2023 | 2023-11-02 | $36.01M | $37.28M | -3.41 % |
| Jun 2023 | 2023-08-02 | $37.58M | $36.23M | 3.72 % |
FAQ
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics (KPTI) is scheduled to report earnings on July 31, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?
The Actual EPS was $-0.32, which beat the estimate of $-0.33.
What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?
The Actual Revenue was $33.1M, which missed the estimate of $34.5M.
Browse earnings estimates, EPS, and revenue on all stocks.